Siegfried opens new quality control laboratory in Minden Page 1

Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen, Switzerland, opened its new state-of-the-art lab in Minden, Germany. The new facility houses workstations for more than 60 employees and high-precision equipment on more than 600 square meters of space. The new lab combines several quality control units in one location, creating synergies and efficiencies and increasing the overall quality control capacity at the site.

The facility will provide the additional quality control capabilities required following the completion of the new large-scale production facility, which is currently under construction. The new production facility will house approximately 100 cubic meters of additional reactor capacity and will significantly increase capacity for Siegfried’s Drug Substance business, expanding the technological capabilities and flexibility of Siegfried’s global network.

Reto Suter, interim Chief Executive Officer and Chief Financial Officer: “The new laboratory facility further strengthens our manufacturing site in Minden and underscores our commitment to providing the most advanced quality control services to our customers, ensuring the safety of the products we produce for millions of patients worldwide. It underscores our dedication to operating a world-class pharmaceutical manufacturing network.”

With the opening of the new lab and the factory under construction, Siegfried is further strengthening its footprint in Germany, where it has two locations in Minden and Hameln. At its two German locations, Siegfried produces a wide range of active pharmaceutical ingredients (APIs) as well as finished medicines such as vials and ampoules.